FDA Approved: TETRABENAZINE — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved Bionpharma Inc.'s original Abbreviated New Drug Application for tetrabenazine, a generic treatment for chorea associated with Huntington's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Tetrabenazine (tetrabenazine)

Snippet

ORIG AP for TETRABENAZINE (TETRABENAZINE)